ViaDerma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VDRM research report →
Price Chart
About the company
ViaDerma, Inc. , a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas.
- CEO
- Christopher A Otiko
- IPO
- 2014
- Employees
- 75
- HQ
- Las Vegas, NV, US
Get TickerSpark's AI analysis on VDRM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $246.74K
- P/E
- 57.48
- PEG
- -0.11
- P/S
- 0.41
- P/B
- 1.91
- EV/EBITDA
- 6.93
- Div Yield
- 0.00%
- Gross Margin
- 99.97%
- Op Margin
- 30.85%
- Net Margin
- 0.68%
- ROE
- -0.48%
- ROIC
- 41.53%
Latest fiscal year · YoY change
- Revenue
- $600.50K+11.1%
- Gross Profit
- $600.30K+11.1%
- Op Income
- $185.27K
- Net Income
- $4.10K-99.3%
- EPS
- $0.00-100.0%
- OCF Growth
- +111.7%
- FCF Growth
- +111.7%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.20
- RSI (14)
- 46
- Avg Volume
- 92.28K
No earnings-call transcripts are available for VDRM yet.
- Free Float
- 10.2%
- Shares Outstanding
- 1.23B
- Float Shares
- 125.60M
Our VDRM coverage
Recent articles, reports, and earnings notes.
No research on VDRM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VDRM report →ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance
globenewswire.com · Jun 4
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
globenewswire.com · Aug 13
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
globenewswire.com · Aug 1
ViaDerma Provides Highlights of Quarterly Financial Report
globenewswire.com · Jun 6
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
globenewswire.com · Oct 24
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
globenewswire.com · Oct 4
ViaDerma, Inc. Files Amended Financial Statements
globenewswire.com · Aug 24
ViaDerma, Inc. Provides Updates on Current Business Activities
globenewswire.com · Jun 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.